Corteva, Inc. (NYSE:CTVA) Shares Purchased by Stifel Financial Corp

Stifel Financial Corp increased its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 62.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 595,900 shares of the company's stock after buying an additional 228,572 shares during the period. Stifel Financial Corp owned 0.09% of Corteva worth $33,943,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Flagship Wealth Advisors LLC acquired a new position in Corteva in the 4th quarter valued at about $25,000. Noble Wealth Management PBC bought a new position in shares of Corteva in the 4th quarter valued at $26,000. Hager Investment Management Services LLC bought a new stake in shares of Corteva in the 4th quarter valued at about $27,000. Golden State Wealth Management LLC bought a new stake in Corteva during the fourth quarter valued at $32,000. Finally, Centricity Wealth Management LLC acquired a new stake in Corteva during the fourth quarter worth approximately $34,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Price Performance

Corteva stock traded up $0.18 during midday trading on Tuesday, reaching $61.74. 473,079 shares of the stock traded hands, compared to its average volume of 3,310,419. The stock has a market cap of $42.17 billion, a P/E ratio of 47.88, a PEG ratio of 1.68 and a beta of 0.73. The stock's fifty day moving average is $60.67 and its 200-day moving average is $60.47. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 12 month low of $50.01 and a 12 month high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CTVA shares. Royal Bank of Canada boosted their price objective on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a report on Friday, February 7th. UBS Group dropped their target price on shares of Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Wells Fargo & Company lifted their target price on Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 28th. KeyCorp lifted their target price on Corteva from $70.00 to $71.00 and gave the company an "overweight" rating in a report on Monday, April 14th. Finally, Bank of America upped their target price on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $68.13.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 26,560 shares of the stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now directly owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This represents a 70.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.14% of the stock is currently owned by company insiders.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.